サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1487495

オルソバイオロジクス市場：世界の産業分析、規模、シェア、成長、動向、2023～2031年予測

Orthobiologics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日: | 発行: Transparency Market Research | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.78円
オルソバイオロジクス市場：世界の産業分析、規模、シェア、成長、動向、2023～2031年予測
出版日: 2024年04月04日
発行: Transparency Market Research
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

オルソバイオロジクス市場-調査範囲

TMRの世界のオルソバイオロジクス市場に関する調査レポートは、2023～2031年までの予測期間における市場の指標について貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。本レポートでは、2023年を基準年、2031年を予測年として、2017～2031年までの世界の整形生物製剤市場の収益と予測を提供しています。また、2023～2031年までの世界のオルソバイオロジクス市場の複合年間成長率（CAGR %）も掲載しています。

本レポートは広範な調査を経て作成されました。1次調査では、主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。2次調査では、主要企業の製品資料、年次報告書、プレスリリース、関連文書などを参照し、オルソバイオロジクス市場を理解しました。

市場スナップショット
2022年の市場規模 62億米ドル
2031年の市場規模 103億米ドル
CAGR 5.7%

本レポートでは、世界のオルソバイオロジクス市場の競合情勢について掘り下げています。世界のオルソバイオロジクス市場で事業を展開する主要企業が特定され、各企業が様々な属性でプロファイルされています。企業概要、財務状況、最近の動向、SWOTは、本レポートで紹介されている世界の整形生物製剤市場の参入企業の属性です。

目次

第1章 序文

第2章 調査前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

  • イントロダクション
  • 市場概要
  • 市場力学
  • 世界市場の分析と予測、2017～2031年

第5章 主要洞察

  • 整形外科疾患の技術的進歩
  • 整形外科疾患の発生率
  • 規制シナリオ：主要国別
  • 償還シナリオ：主要国別
  • 価格分析
  • パイプライン分析
  • 最も効果的な配合剤概要
  • COVID-19パンデミック影響分析

第6章 世界市場分析と予測：製品別

  • イントロダクションと定義
  • 主要調査結果/発展
  • 製品別市場金額予測、2017～2031年
    • 脱灰骨マトリックス（DBM）
    • ハイドロキシアパタイト（HAp）
    • ヒアルロン酸（HA）
    • 硫酸カルシウムマトリックス
    • B-リン酸三カルシウム（B-TCP）
    • B-TCP+HAp
    • DBM+PLGA
    • 再生医療
      • PRP
      • BMAC
      • SVF
      • その他（エクソソームなど）
    • 成長因子
      • BMP2
      • FGF2
      • TGFベータ
      • VEGF
      • その他（IGFなど）
  • 製品別、市場魅力度

第7章 世界市場分析と予測：エンドユーザー別

  • イントロダクションと定義
  • 主要調査結果/発展
  • エンドユーザー別市場金額予測、2017～2031年
    • 病院
    • 整形外科クリニック
    • その他（耳鼻咽喉科クリニックなど）
  • エンドユーザー別、市場魅力度

第8章 世界市場分析・予測：地域別

  • 主要調査結果
  • 地域別市場金額予測
    • 欧州
    • インド
    • その他
  • 国・地域別市場魅力度

第9章 欧州市場の分析と予測

  • ドイツ、英国、フランス、イタリア、スペイン、その他の欧州

第10章 インド市場の分析と予測

第11章 インド、その他市場の分析と予測

第12章 競合情勢

  • 市場競合マトリックス（層別、企業規模別）
  • 企業別シェア分析（2022年）
  • 企業プロファイル
    • Arthrex, Inc.
    • ATEC Spine, Inc.
    • Bioventus
    • Exactech, Inc.
    • Globus Medical
    • Integra Lifesciences Corporation
    • Johnson & Johnson
    • Medtronic plc
    • MTF Biologics
    • NORAKER
    • RTI Surgical
    • Stryker
    • Zimmer Biomet
図表

List of Tables

  • Table 01: Global Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 02: Global Orthobiologics Market Value (US$ Mn) Forecast, by Regenerative Medicine, 2017-2031
  • Table 03: Global Orthobiologics Market Value (US$ Mn) Forecast, by Growth Factors, 2017-2031
  • Table 04: Global Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 05: Global Orthobiologics Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 06: India Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 07: India Orthobiologics Market Value (US$ Mn) Forecast, by Regenerative Medicine, 2017-2031
  • Table 08: India Orthobiologics Market Value (US$ Mn) Forecast, by Growth Factors, 2017-2031
  • Table 09: India Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 10: Europe Orthobiologics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 11: Europe Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 12: Europe Orthobiologics Market Value (US$ Mn) Forecast, by Regenerative Medicine, 2017-2031
  • Table 13: Europe Orthobiologics Market Value (US$ Mn) Forecast, by Growth Factors, 2017-2031
  • Table 14: Europe Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 15: Rest of the World Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 16: Rest of the World Orthobiologics Market Value (US$ Mn) Forecast, by Regenerative Medicine, 2017-2031
  • Table 17: Rest of the World Orthobiologics Market Value (US$ Mn) Forecast, by Growth Factors, 2017-2031
  • Table 18: Rest of the World Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Orthobiologics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Orthobiologics Market Share Analysis, by Product, 2022
  • Figure 03: Global Orthobiologics Market Share Analysis, by End-user, 2022
  • Figure 04: Global Orthobiologics Market Value (US$ Mn) Share Analysis, by Product, 2022 and 2031
  • Figure 05: Global Orthobiologics Market Share Analysis, by Product, 2022
  • Figure 06: Global Orthobiologics Market Share Analysis, by Product, 2031
  • Figure 07: Global Orthobiologics Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 08: Global Orthobiologics Market Revenue (US$ Mn), by Demineralized Bone Matrix (DBM), 2017-2031
  • Figure 09: Global Orthobiologics Market Value Share Analysis, by Demineralized Bone Matrix (DBM), 2022 and 2031
  • Figure 10: Global Orthobiologics Market Revenue (US$ Mn), by Hydroxyapatite (HAp), 2017-2031
  • Figure 11: Global Orthobiologics Market Value Share Analysis, by Hydroxyapatite (HAp), 2022 and 2031
  • Figure 12: Global Orthobiologics Market Revenue (US$ Mn), by Hyaluronic acid (HA), 2017-2031
  • Figure 13: Global Orthobiologics Market Value Share Analysis, by Hyaluronic acid (HA), 2022 and 2031
  • Figure 14: Global Orthobiologics Market Revenue (US$ Mn), by Calcium Sulfate Matrix, 2017-2031
  • Figure 15: Global Orthobiologics Market Value Share Analysis, by Calcium Sulfate Matrix, 2022 and 2031
  • Figure 16: Global Orthobiologics Market Revenue (US$ Mn), by B-tricalcium phosphate (B-TCP), 2017-2031
  • Figure 17: Global Orthobiologics Market Value Share Analysis, by B-tricalcium phosphate (B-TCP), 2022 and 2031
  • Figure 18: Global Orthobiologics Market Revenue (US$ Mn), by B-TCP + HAp, 2017-2031
  • Figure 19: Global Orthobiologics Market Value Share Analysis, by B-TCP + HAp, 2022 and 2031
  • Figure 20: Global Orthobiologics Market Revenue (US$ Mn), by DBM + HA, 2017-2031
  • Figure 21: Global Orthobiologics Market Value Share Analysis, by DBM + HA, 2022 and 2031
  • Figure 22: Global Orthobiologics Market Revenue (US$ Mn), by B-TCP + PLGA, 2017-2031
  • Figure 23: Global Orthobiologics Market Value Share Analysis, by B-TCP + PLGA, 2022 and 2031
  • Figure 24: Global Orthobiologics Market Revenue (US$ Mn), by Regenerative medicine, 2017-2031
  • Figure 25: Global Orthobiologics Market Value Share Analysis, by Regenerative medicine, 2022 and 2031
  • Figure 26: Global Orthobiologics Market Revenue (US$ Mn), by Growth Factors, 2017-2031
  • Figure 27: Global Orthobiologics Market Value Share Analysis, by Growth Factors, 2022 and 2031
  • Figure 28: Global Orthobiologics Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031
  • Figure 29: Global Orthobiologics Market Share Analysis, by End-user, 2022
  • Figure 30: Global Orthobiologics Market Share Analysis, by End-user, 2031
  • Figure 31: Global Orthobiologics Market Revenue (US$ Mn), by Hospitals, 2017-2031
  • Figure 32: Global Orthobiologics Market Value Share Analysis, by Hospitals, 2022 and 2031
  • Figure 33: Global Orthobiologics Market Revenue (US$ Mn), by Orthopedic Clinics, 2017-2031
  • Figure 34: Global Orthobiologics Market Value Share Analysis, by Orthopedic Clinics, 2022 and 2031
  • Figure 35: Global Orthobiologics Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 36: Global Orthobiologics Market Value Share Analysis, by Others, 2022 and 2031
  • Figure 37: Global Orthobiologics Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 38: Global Orthobiologics Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 39: India Orthobiologics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 40: India Orthobiologics Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 41: India Orthobiologics Market Attractiveness Analysis, Product, 2023-2031
  • Figure 42: India Orthobiologics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 43: India Orthobiologics Market Attractiveness Analysis, End-user, 2023-2031
  • Figure 44: Europe Orthobiologics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 45: Europe Orthobiologics Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 46: Europe Orthobiologics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 47: Europe Orthobiologics Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 48: Europe Orthobiologics Market Attractiveness Analysis, Product, 2023-2031
  • Figure 49: Europe Orthobiologics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 50: Europe Orthobiologics Market Attractiveness Analysis, End-user, 2023-2031
  • Figure 51: Rest of the World Orthobiologics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 52: Rest of the World Orthobiologics Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 53: Rest of the World Orthobiologics Market Attractiveness Analysis, Product, 2023-2031
  • Figure 54: Rest of the World Orthobiologics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 55: Rest of the World Orthobiologics Market Attractiveness Analysis, End-user, 2023-2031
  • Figure 56: Market Share Analysis by Company (2022)
目次
Product Code: TMRGL1747

Orthobiologics Market - Scope of Report

TMR's report on the global orthobiologics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global orthobiologics market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global orthobiologics market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the orthobiologics market.

Market Snapshot
Market Value in 2022US$ 6.2 Bn
Market Value in 2031US$ 10.3 Bn
CAGR5.7%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global orthobiologics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global orthobiologics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global orthobiologics market.

The report delves into the competitive landscape of the global orthobiologics market. Key players operating in the global orthobiologics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global orthobiologics market profiled in this report.

Key Questions Answered in Global orthobiologics Market Report:

  • What is the sales/revenue generated by orthobiologics across all regions during the forecast period?
  • What are the opportunities in the global orthobiologics market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Orthobiologics Market - Research Objectives and Research Approach

The comprehensive report on the global orthobiologics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global orthobiologics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global orthobiologics market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Orthobiologics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Orthobiologics Market Analysis and Forecasts, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Technological Advancements in Orthobiologics
  • 5.2. Incidence of Orthopedic Disorders
  • 5.3. Regulatory Scenario, by Key Countries
  • 5.4. Reimbursement Scenario, by Key Countries
  • 5.5. Pricing Analysis of Orthobiologics
  • 5.6. Pipeline Analysis
  • 5.7. Overview of Most Effective Combinations of Orthobiologics products
  • 5.8. COVID-19 Pandemic Impact Analysis

6. Global Orthobiologics Market Analysis and Forecasts, By Product

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Product, 2017-2031
    • 6.3.1. Demineralized Bone Matrix (DBM)
    • 6.3.2. Hydroxyapatite (HAp)
    • 6.3.3. Hyaluronic acid (HA)
    • 6.3.4. Calcium Sulfate Matrix
    • 6.3.5. B-tricalcium phosphate (B-TCP)
    • 6.3.6. B-TCP + HAp
    • 6.3.7. DBM + PLGA
    • 6.3.8. Regenerative Medicine
      • 6.3.8.1. PRP
      • 6.3.8.2. BMAC
      • 6.3.8.3. SVF
      • 6.3.8.4. Others (Exosome, etc.)
    • 6.3.9. Growth Factors
      • 6.3.9.1. BMP2
      • 6.3.9.2. FGF2
      • 6.3.9.3. TGF beta
      • 6.3.9.4. VEGF
      • 6.3.9.5. Others (IGF, etc.)
  • 6.4. Market Attractiveness By Product

7. Global Orthobiologics Market Analysis and Forecasts, By End-user

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By End-user, 2017-2031
    • 7.3.1. Hospitals
    • 7.3.2. Orthopedic Clinics
    • 7.3.3. Others (ENT Clinics, etc.)
  • 7.4. Market Attractiveness By End-user

8. Global Orthobiologics Market Analysis and Forecasts, By Region

  • 8.1. Key Findings
  • 8.2. Market Value Forecast By Region
    • 8.2.1. Europe
    • 8.2.2. India
    • 8.2.3. Rest of the World
  • 8.3. Market Attractiveness By Country/Region

9. Europe Orthobiologics Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. Market Value Forecast By Product, 2017-2031
    • 9.2.1. Demineralized Bone Matrix (DBM)
    • 9.2.2. Hydroxyapatite (HAp)
    • 9.2.3. Hyaluronic acid (HA)
    • 9.2.4. Calcium Sulfate Matrix
    • 9.2.5. B-tricalcium phosphate (B-TCP)
    • 9.2.6. B-TCP + Hap
    • 9.2.7. DBM + PLGA
    • 9.2.8. B-TCP + PLGA
    • 9.2.9. Regenerative Medicine
      • 9.2.9.1. PRP
      • 9.2.9.2. BMAC
      • 9.2.9.3. SVF
      • 9.2.9.4. Others (Exosome, etc.)
    • 9.2.10. Growth Factors
      • 9.2.10.1. BMP2
      • 9.2.10.2. FGF2
      • 9.2.10.3. TGF beta
      • 9.2.10.4. VEGF
      • 9.2.10.5. Others (IGF, etc.)
  • 9.3. Market Value Forecast By End-user, 2017-2031
    • 9.3.1. Hospitals
    • 9.3.2. Orthopedic Clinics
    • 9.3.3. Others (ENT Clinics, etc.)
  • 9.4. Market Value Forecast By Country, 2017-2031
    • 9.4.1. Germany
    • 9.4.2. U.K.
    • 9.4.3. France
    • 9.4.4. Italy
    • 9.4.5. Spain
    • 9.4.6. Rest of Europe
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Product
    • 9.5.2. By End-user
    • 9.5.3. By Country

10. India Orthobiologics Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast By Product, 2017-2031
    • 10.2.1. Demineralized Bone Matrix (DBM)
    • 10.2.2. Hydroxyapatite (HAp)
    • 10.2.3. Hyaluronic acid (HA)
    • 10.2.4. Calcium Sulfate Matrix
    • 10.2.5. B-tricalcium phosphate (B-TCP)
    • 10.2.6. B-TCP + HAp
    • 10.2.7. DBM + PLGA
    • 10.2.8. B-TCP + PLGA
    • 10.2.9. Regenerative Medicine
      • 10.2.9.1. PRP
      • 10.2.9.2. BMAC
      • 10.2.9.3. SVF
      • 10.2.9.4. Others (Exosome, etc.)
    • 10.2.10. Growth Factors
      • 10.2.10.1. BMP2
      • 10.2.10.2. FGF2
      • 10.2.10.3. TGF beta
      • 10.2.10.4. VEGF
      • 10.2.10.5. Others (IGF, etc.)
  • 10.3. Market Value Forecast By End-user, 2017-2031
    • 10.3.1. Hospitals
    • 10.3.2. Orthopedic Clinics
    • 10.3.3. Others (ENT Clinics, etc.)
  • 10.4. Market Attractiveness Analysis
    • 10.4.1. By Product
    • 10.4.2. By End-user

11. Rest of the World Orthobiologics Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Product, 2017-2031
    • 11.2.1. Demineralized Bone Matrix (DBM)
    • 11.2.2. Hydroxyapatite (HAp)
    • 11.2.3. Hyaluronic acid (HA)
    • 11.2.4. Calcium Sulfate Matrix
    • 11.2.5. B-tricalcium phosphate (B-TCP)
    • 11.2.6. B-TCP + HAp
    • 11.2.7. DBM + PLGA
    • 11.2.8. B-TCP + PLGA
    • 11.2.9. Regenerative Medicine
      • 11.2.9.1. PRP
      • 11.2.9.2. BMAC
      • 11.2.9.3. SVF
      • 11.2.9.4. Others (Exosome, etc.)
    • 11.2.10. Growth Factors
      • 11.2.10.1. BMP2
      • 11.2.10.2. FGF2
      • 11.2.10.3. TGF beta
      • 11.2.10.4. VEGF
      • 11.2.10.5. Others (IGF, etc.)
  • 11.3. Market Value Forecast By End-user, 2017-2031
    • 11.3.1. Hospitals
    • 11.3.2. Orthopedic Clinics
    • 11.3.3. Others (ENT Clinics, etc.)
  • 11.4. Market Attractiveness Analysis
    • 11.4.1. By Product
    • 11.4.2. By End-user

12. Competition Landscape

  • 12.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 12.2. Market Share Analysis By Company (2022)
  • 12.3. Company Profiles
    • 12.3.1. Arthrex, Inc.
      • 12.3.1.1. Company Overview
      • 12.3.1.2. Financial Overview
      • 12.3.1.3. Product Portfolio
      • 12.3.1.4. Business Strategies
      • 12.3.1.5. Recent Developments
    • 12.3.2. ATEC Spine, Inc.
      • 12.3.2.1. Company Overview
      • 12.3.2.2. Financial Overview
      • 12.3.2.3. Product Portfolio
      • 12.3.2.4. Business Strategies
      • 12.3.2.5. Recent Developments
    • 12.3.3. Bioventus
      • 12.3.3.1. Company Overview
      • 12.3.3.2. Financial Overview
      • 12.3.3.3. Product Portfolio
      • 12.3.3.4. Business Strategies
      • 12.3.3.5. Recent Developments
    • 12.3.4. Exactech, Inc.
      • 12.3.4.1. Company Overview
      • 12.3.4.2. Financial Overview
      • 12.3.4.3. Product Portfolio
      • 12.3.4.4. Business Strategies
      • 12.3.4.5. Recent Developments
    • 12.3.5. Globus Medical
      • 12.3.5.1. Company Overview
      • 12.3.5.2. Financial Overview
      • 12.3.5.3. Product Portfolio
      • 12.3.5.4. Business Strategies
      • 12.3.5.5. Recent Developments
    • 12.3.6. Integra Lifesciences Corporation
      • 12.3.6.1. Company Overview
      • 12.3.6.2. Financial Overview
      • 12.3.6.3. Product Portfolio
      • 12.3.6.4. Business Strategies
      • 12.3.6.5. Recent Developments
    • 12.3.7. Johnson & Johnson
      • 12.3.7.1. Company Overview
      • 12.3.7.2. Financial Overview
      • 12.3.7.3. Product Portfolio
      • 12.3.7.4. Business Strategies
      • 12.3.7.5. Recent Developments
    • 12.3.8. Medtronic plc
      • 12.3.8.1. Company Overview
      • 12.3.8.2. Financial Overview
      • 12.3.8.3. Product Portfolio
      • 12.3.8.4. Business Strategies
      • 12.3.8.5. Recent Developments
    • 12.3.9. MTF Biologics
      • 12.3.9.1. Company Overview
      • 12.3.9.2. Financial Overview
      • 12.3.9.3. Product Portfolio
      • 12.3.9.4. Business Strategies
      • 12.3.9.5. Recent Developments
    • 12.3.10. NORAKER
      • 12.3.10.1. Company Overview
      • 12.3.10.2. Financial Overview
      • 12.3.10.3. Product Portfolio
      • 12.3.10.4. Business Strategies
      • 12.3.10.5. Recent Developments
    • 12.3.11. RTI Surgical
      • 12.3.11.1. Company Overview
      • 12.3.11.2. Financial Overview
      • 12.3.11.3. Product Portfolio
      • 12.3.11.4. Business Strategies
      • 12.3.11.5. Recent Developments
    • 12.3.12. Stryker
      • 12.3.12.1. Company Overview
      • 12.3.12.2. Financial Overview
      • 12.3.12.3. Product Portfolio
      • 12.3.12.4. Business Strategies
      • 12.3.12.5. Recent Developments
    • 12.3.13. Zimmer Biomet
      • 12.3.13.1. Company Overview
      • 12.3.13.2. Financial Overview
      • 12.3.13.3. Product Portfolio
      • 12.3.13.4. Business Strategies
      • 12.3.13.5. Recent Developments